Document Detail


Enhancement of visit adherence in the national beta-blocker heart attack trial.
MedLine Citation:
PMID:  3891227     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Efforts were made in the Beta Blocker Heart Trial (BHAT), a double-blind study of 3837 post-MI patients, to enhance visit adherence, a measure of compliance that is not subjective and can be easily monitored. Of the required visits, 93.9% were completed in the window, 3.9% of the patients were classified as dropouts and 12 persons were lost to follow-up. Methods used to enhance compliance varied with circumstances but included appointment reminders, assistance with transportation, minimal waiting times, newsletters, continuity of care, involvement of family members, and close contact with private physicians. Comparisons of the BHAT visit adherence rates to those from other clinical trials are difficult to make because there are few reports in the literature regarding follow-up in large multicenter clinical trials. However, data obtained through personal communications, as well as published reports, indicate that adherence in primary prevention trials was generally less than that of secondary prevention trials. Adherence rates in the BHAT tended to be slightly higher than those of comparable trials.
Authors:
R L Bell; J D Curb; L M Friedman; K M McIntyre; C Payton-Ross
Related Documents :
17123387 - Inhibitor treatment in haemophilias a and b: summary statement for the 2006 internation...
22340187 - Why do anxious children become depressed teenagers? the role of social evaluative threa...
22495967 - The bereavement exclusion and dsm-5.
1609177 - The use of subjective rankings in clinical trials with an application to cardiovascular...
23548887 - Topical retinoids in oral lichen planus treatment: an overview.
16015067 - Atopic profiles, familial histories, and coexisting conditions associated with hand ecz...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Controlled clinical trials     Volume:  6     ISSN:  0197-2456     ISO Abbreviation:  Control Clin Trials     Publication Date:  1985 Jun 
Date Detail:
Created Date:  1985-08-12     Completed Date:  1985-08-12     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8006242     Medline TA:  Control Clin Trials     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  89-101     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Appointments and Schedules
Clinical Trials as Topic
Double-Blind Method
Humans
Middle Aged
Myocardial Infarction / prevention & control*
Patient Compliance*
Patient Dropouts
Propranolol / therapeutic use*
Random Allocation
Recurrence
Time Factors
Grant Support
ID/Acronym/Agency:
N01-HV-7-2948/HV/NHLBI NIH HHS
Chemical
Reg. No./Substance:
525-66-6/Propranolol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Demonstration of innominate artery aneurysm by magnetic resonance/imaging.
Next Document:  The role of analytical techniques in the diagnosis of asbestos-associated disease.